FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/09/009902 [Registered on: 25/09/2017] Trial Registered Prospectively
Last Modified On: 22/09/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   COMPARISON OF A LOCAL ANAESTHETIC ALONE AND IN COMBINATION WITH AN ANALGESIC AND AN ANTIHYPERTENSIVE DRUG FOR POSTOPERATIVE PAIN RELIEF IN CHILDREN VIA CAUDAL ROUTE. 
Scientific Title of Study   A comparative study of levobupivacaine, levobupivacaine with ketamine and levobupivacaine with dexmedetomidine in caudal block for post operative pain relief in paediatric patients. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  GANESH KUMAR RAM 
Designation  JUNIOR RESIDENT 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  DEPARTMENT OF ANAESTHESIOLOGY,INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, SHEIKHPURA,PATNA.

Patna
BIHAR
800014
India 
Phone  8544117808  
Fax    
Email  GANESHKR05@GMAIL.COM  
 
Details of Contact Person
Scientific Query
 
Name  PRAKASH KUMAR DUBEY 
Designation  PROFESSOR 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  DEPARTMENT OF ANAESTHESIOLOGY, IGIMS,

Patna
BIHAR
800014
India 
Phone    
Fax    
Email  PKDUBEY@HOTMAIL.COM  
 
Details of Contact Person
Public Query
 
Name  PRAKASH KUMAR DUBEY 
Designation  PROFESSOR 
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  DEPARTMENT OF ANAESTHESIOLOGY, IGIMS,

Patna
BIHAR
800014
India 
Phone    
Fax    
Email  PKDUBEY@HOTMAIL.COM  
 
Source of Monetary or Material Support  
DEPARTMENT OF ANAESTHESIOLOGY, IGIMS, PATNA 800014, BIHAR. 
 
Primary Sponsor  
Name  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES 
Address  SHEIKHPURA, PATNA, 800014,BIHAR, INDIA. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
GANESH KUMAR RAM  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES.  OT COMPLEX,FIRST FLOOR,IGIMS
Patna
BIHAR 
8544117808
8544117808
GANESHKR05@GMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, SHEIKHPURA, PATNA-14  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  AMERICAN SOCIETY OF ANAESTHESIOLOGY GRADE 1 AND 2,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  LEVOBUPIVACAINE  LEVOBUPIVACAINE 0.25% AT A DOSE OF 0.75 MILILITER/KG BODY WEIGHT DILUTED IN NORMAL SALINE 0.9% 
Intervention  LEVOBUPIVACAINE WITH DEXMEDETOMIDINE  LEVOBUPIVACAINE 0.25% AT A DOSE OF 0.75 MILILITER/KG OF BODY WEIGHT WITH DEXMEDETOMIDINE 1 MICROGRAM/KG OF BODY WEIGHT 
Intervention  LEVOBUPIVACAINE WITH KETAMINE  LEVOBUPIVACAINE 0.25% AT A DOSE OF 0.75MILILITER/KG OF BODY WEIGHT WITH KETAMINE 0.05% AT A DOSE OF 0.5 MILIGRAM/KG BODY WEIGHT 
 
Inclusion Criteria  
Age From  3.00 Month(s)
Age To  7.00 Year(s)
Gender  Both 
Details  1.PATIENTS OF ASA PHYSICAL STATUS 1 AND 2.
2.PATIENTS BETWEEN 3 MONTH TO 7 YEARS OF AGE OF EITHER SEX.
3.PARENTS ABLE TO COMPREHEND TO PARTICIPATE.
4.PATIENTS IN WHOM LEVOBUPIVACAINE IS INDICATED FOR CAUDAL BLOCK.  
 
ExclusionCriteria 
Details  1.PARENTS REFUSAL TO PARTICIPATE.
2.CONTRAINDICATION TO USE OF KETAMINE OR DEXMEDETOMIDINE.
3.PATIENTS WITH KNOWN SENSITIVITY TO LEVOBUPIVACAINE,KETAMINE OF DEXMEDETOMIDINE.
4.PATIENTS ON CONCOMITANT ANALGESIC OR SEDATIVE MEDICATION.
5.PATIENTS WITH PRESENCE OF INFECTION AT THE SITE OF CAUDAL BLOCK,COGULOPATHY OR ANY NEUROLOGICAL ILLNESS. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
POST OPERATIVE PAIN RELIEF BY FLACC SCORE.  15 MINUTES, 45 MINUTES, 75 MINUTES, 125 MINUTES, 155 MINUTES, 185 MINUTES, 215 MINUTES, 275 MINUTES, 335 MINUTES. 
 
Secondary Outcome  
Outcome  TimePoints 
SEDATION, NAUSEA VOMITING, RESPIRATORY DEPRESSION, URINARY RETENTION.  15 MINUTES, 45 MINUTES, 75 MINUTES, 125 MINUTES, 155 MINUTES, 185 MINUTES, 215 MINUTES, 275 MINUTES, 335 MINUTES. 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/12/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   PLAN TO PUBLISH AFTER COMPLETION OF STUDY. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   COMPARATIVE STUDY OF LEVOBUPIVACAINE,LEVOBUPIVACAINE WITH KETAMINE AND LEVOBUPIVACAINE WITH DEXMEDETOMIDINE IN CAUDAL BLOCK FOR POST OPERATIVE PAIN RELIEF IN PAEDIATRICS PATIENTS. 
Close